| 证券代码 | AMRI.O |
| 证券名称 | 奥尔巴尼分子研究 |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 1999-02-04 |
| 首发价格(元) | 20 USD |
| 首发数量(股) | 2500000 |
| 首发募资额(元) | 50,000,000.00 USD |
| 首发主承销商 | ING Baring Furman Selz LLC,Hambrecht & Quist LLC |
| 货币单位 | USD |
| 公司名称 | Albany Molecular Research, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 26 Corporate Circle, Albany, New York, USA |
| 成立日期 | 1998 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.amriglobal.com |
| 电话 | +1 (518) 512-2000 |
| 传真 | - |
| 公司简介 | Albany Molecular Research, Inc. is a global contract research and manufacturing organization that has been working with the Life Sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, their key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP), and Fine Chemicals (FC). |